| Helsinn Boosts Oncology Portfolio with BridgeBio’s Infigratinib |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Janssen Ups Influenza Investment with US$780 M Bet on Cidara’s AVC Platform |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Merck KGaA Expands Head and Neck Cancer Therapy Portfolio with Debiopharm’s Xevinapant |
Abstract
pdf
html
|
|
Debadrita Paul & Michelle Liu |
|
| Pfizer Pledges up to US$4.4 B for Myovant’s Orgovyx |
Abstract
pdf
html
|
|
Sasha Yachu & Michelle Liu |
|
| Roche Advances Infectious Disease Diagnostic Portfolio with US$1.8 B GenMark Acquisition |
Abstract
pdf
html
|
|
Debadrita Paul & Michelle Liu |
|
| Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B |
Abstract
pdf
html
|
|
Swati Sharan & Michelle Liu |
|
